Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug [Yahoo! Finance]
UMB Financial Corporation (UMBF)
Last umb financial corporation earnings: 4/28 05:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
umbfinancial.com/investor-relations
Company Research
Source: Yahoo! Finance
federal approval for three drugs, 1-1/2 months after a federal judge abruptly dismissed an earlier version of the case. The lawsuit accused Bristol Myers of depriving holders of "contingent value rights" (CVR) an extra $9 per share in cash by dragging its heels in seeking approval of the drugs, including the cancer drug Breyanzi, by specified deadlines. It said Bristol Myers did this to avoid a big payout. On Sept. 30, U.S. District Judge Jesse Furman in Manhattan ruled that the plaintiff UMB Bank had never been properly appointed trustee to represent the CVR holders. He said this "inexplicable failure" doomed the earlier lawsuit that UMB filed after purportedly replacing a different trustee, and 17 months after Bristol Myers bought Celgene for $80.3 billion. In Thursday's complaint, UMB said it has addressed the judge's concerns and been confirmed as trustee, entitling it to sue. Bristol Myers' estimated $6.7 billion liability is up from $6.4 billion mentioned in earlier cour
Show less
Read more
Impact Snapshot
Event Time:
UMBF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UMBF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UMBF alerts
High impacting UMB Financial Corporation news events
Weekly update
A roundup of the hottest topics
UMBF
News
- UMB Financial Co. (NASDAQ: UMBF) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $156.00 price target on the stock.MarketBeat
- Discover US Stocks That May Be Trading Below Estimated Value In November 2024 [Yahoo! Finance]Yahoo! Finance
- 3 Stocks Possibly Trading At Discounts Of Up To 48.1% [Yahoo! Finance]Yahoo! Finance
- Discover XD And 2 More Stocks Estimated To Be Trading At A Discount [Yahoo! Finance]Yahoo! Finance
- US Exchange: Discover 3 Stocks That May Be Priced Below Their Estimated Value [Yahoo! Finance]Yahoo! Finance
UMBF
Earnings
- 10/29/24 - Beat
UMBF
Sec Filings
- 11/12/24 - Form 4
- 11/12/24 - Form 4
- 11/7/24 - Form 144
- UMBF's page on the SEC website